ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Examples Of CCOP Cancer Control Projects Listed

May 16, 1986

Guest Editorial: Chernobyl Doctor’s Notes From Fukushima

April 1, 2011

In Brief: Eight Minority CCP Awards Confirmed, Four More Coming; General Motors Winners Named

June 15, 1990

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012

House Committee Adds $4.1 Billion To HHS Budget, Funds Not Expected To Help NIH.

May 12, 2006

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987